Faculty

Jonathan D Sugimoto

Affiliate Assistant Professor, Epidemiology


Education

PhD Epidemiology, University of Washington, 2010
MHS International Health, Johns Hopkins University, 2002
BS Biology, Calvin College, 2000

Contact


WA

Bio

Jonathan Sugimoto is an Epidemiologist and Investigator with the Seattle Epidemiologic Research and Information Center (ERIC) at the United States Department of Veteran Affairs (VA) Puget Sound Health Care Medical Center, Seattle WA. The Seattle ERIC one of a network of Epidemiology Centers supported by the Cooperative Studies Program of the VA’s Office of Research and Development.

Research Interests

Dr. Jonathan Sugimoto is a quantitative infectious disease epidemiologist whose research focuses on the estimation and modeling of the burden and prevention of communicable pathogens in humans.  His research experience extends from designing, implementing, analyzing, and reporting observational field studies and randomized vaccine trials, to developing and applying statistical methods and models for reducing bias in observational/ecological studies of vaccine efficacy/effectiveness.  He has used a wide variety of statistical methods and approaches to infer and model vaccine-preventable disease burden and vaccine effects for populations that range from the very local to the global.  Jonathan also has experience applying geostatistical methods to geolocated infectious disease and nutritional epidemiologic data.  Dr. Sugimoto has conducted global health research across sub-Saharan Africa and South Asia.  Recently, Dr. Sugimoto’s work has focused on the design and analysis of studies and trial of the effectiveness of vaccines against neglected enteric diseases in low-resource tropical settings, such as typhoid, cholera, and rotavirus. 

Dr. Sugimoto recently joined the Seattle Epidemiologic Research and Information Center (VA Puget Sound Health Care System), where he is an investigator with several SARS-CoV-2/COVID-19 related projects, including serving as the Program Director for a national prospective cohort study (CSP #2028) of the natural history, immune response, transmission, and clinical outcomes of symptomatic SARS-CoV-2 infection among Veteran-users of the VA health care system.

Recent Publications (PubMed)

Overcoming Vaccine Inequities and Research Gaps in Africa: Challenges and Opportunities Identified During the COVID-19 Pandemic.
(2025 Jul 22)
Clin Infect Dis 80(Supplement_1): S9-S15
Kim CL, Thwe TT, Espinoza LMC, Sugimoto JD, Fallah MP, Jeon HJ, Rakotozandrindrainy R, Owusu-Dabo E, Bassiahi AS, Lunguya O, Jani IV, Marks F, Tadesse BT

Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique.
(2025 Jul 22)
Clin Infect Dis 80(Supplement_1): S37-S46
Ramgi P, Siribie M, Rakotozandrindrainy N, Bule O, Shrivastava H, Chambule L, Park EL, Fernando C, Boque J, Macuiana R, Razafimanantsoa R, Rakotozandrindrainy N, Razafindrabe TJL, Rakotoarisoa AN, Raminosoa TM, Derandrainy HL, Rakotoson MM, de Silva CSS, Mutombene M, Massinga C, Langa JP, Guarnacci T, Kang SSY, Jo SK, Jeon HJ, Excler JL, Yang Y, Wang S, Sugimoto JD, Yang JS, Shim BS, Binger T, Capitine IU, Aziz AB, Park JY, Kim DR, Rakotozandrindrainy R, Jani IV, Tadesse BT, Marks F

COVID-19 Surveillance in Madagascar and Urban Burkina Faso: Addressing Underreporting of Disease Burden Through Integrative Analysis of Diverse Data Streams.
(2025 Jul 22)
Clin Infect Dis 80(Supplement_1): S16-S28
Rakotozandrindrainy N, Kang SSY, Wandji Nana LR, Sugimoto JD, Wang YT, Rakotozandrindrainy N, Razafindrabe TJL, Raminosoa TM, Hong SL, Razafindrakalia M, Nyirenda G, Binger T, Higginson EE, Jeon HJ, Wangmo N, Cakpo GE, You Y, Tadesse BT, Soura AB, Rakotozandrindrainy R, Marks F

Real-world Evaluation of the Effectiveness of Sinopharm COVID-19 Vaccine Against Symptomatic COVID-19 in an Omicron-Dominant Setting in Mozambique: A Test-Negative, Case-Control Study.
(2025 Jul 22)
Clin Infect Dis 80(Supplement_1): S47-S56
Capitine IU, Aziz AB, Manhiça A, Tivane I, Zumba A, Nhumba M, Rebocho Z, Miquicene E, Nguenha N, Langa J, Shrivastava H, Yang Y, Wang S, Park JY, Kyung SE, You YA, Lee H, Park EL, Rakotozandrindrainy R, Kyoung Jo S, Sherliker C, Sugimoto JD, Jeon HJ, Binger T, Siribie M, Kim DR, Jani IV, Marks F, Tadesse BT

Epidemiology, Immunology and Clinical Characteristics of COVID-19 (EPIC(3))-Database of a prospective longitudinal observational study within the Veterans Health Administration.
(2025)
Front Public Health 13(): 1535315
Huang L, Li X, Kamal SI, Sugimoto JD, Liu CH, Wang T, Morelli DK, Midthun JB, Pakanati VR, Deardorff KV, Sporleder JL, Lopez J, Holodniy M, Smith NL, Lee JS, Shah JA, Ross JM

Show complete publication list

In the News

No news articles at this time.